{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:23:22Z","timestamp":1790011402240,"version":"4.0.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s12325-021-01962-w","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T17:04:09Z","timestamp":1637255049000},"page":"504-517","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Effectiveness, Adherence, and Safety of Evolocumab in a Swiss Multicenter Prospective Observational Study"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2493-3505","authenticated-orcid":false,"given":"David","family":"Nanchen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3212-1272","authenticated-orcid":false,"given":"David","family":"Carballo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7716-2791","authenticated-orcid":false,"given":"Stefan","family":"Bilz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4070-6513","authenticated-orcid":false,"given":"Hans","family":"Rickli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos C.","family":"Koskinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3178-9131","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Mach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1120-6405","authenticated-orcid":false,"given":"Christian","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8526-4459","authenticated-orcid":false,"given":"Carmela","family":"Crljenica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4698-5274","authenticated-orcid":false,"given":"Mariagrazia","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8616-6287","authenticated-orcid":false,"given":"Nina","family":"Reichert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8197-8892","authenticated-orcid":false,"given":"Isabella","family":"Sudano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,18]]},"reference":[{"issue":"16","key":"1962_CR1","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1056\/NEJMra1806939","volume":"381","author":"ED Michos","year":"2019","unstructured":"Michos ED, McEvoy JW, Blumenthal RS. Lipid management for the prevention of atherosclerotic cardiovascular disease. N Engl J Med. 2019;381(16):1557\u201367.","journal-title":"N Engl J Med"},{"issue":"15","key":"1962_CR2","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1161\/CIRCULATIONAHA.117.030950","volume":"137","author":"RP Giugliano","year":"2018","unstructured":"Giugliano RP, Cannon CP, Blazing MA, et al. Benefit of adding ezetimibe to statin therapy on cardiovascular outcomes and safety in patients with versus without diabetes mellitus. Circulation. 2018;137(15):1571\u201382.","journal-title":"Circulation"},{"issue":"18","key":"1962_CR3","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","volume":"376","author":"MS Sabatine","year":"2017","unstructured":"Sabatine MS, Giugliano RP, Keech AC, et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med. 2017;376(18):1713\u201322.","journal-title":"N Engl J Med"},{"issue":"22","key":"1962_CR4","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","volume":"379","author":"GG Schwartz","year":"2018","unstructured":"Schwartz GG, Steg PG, Szarek M, et al. Alirocumab and cardiovascular outcomes after acute coronary syndrome. N Engl J Med. 2018;379(22):2097\u2013107.","journal-title":"N Engl J Med"},{"issue":"9753","key":"1962_CR5","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","volume":"376","author":"C Baigent","year":"2010","unstructured":"Cholesterol Treatment Trialists\u2019 Collaboration, Baigent C, Blackwell L, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376(9753):1670\u201381.","journal-title":"Lancet"},{"issue":"39","key":"1962_CR6","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","volume":"37","author":"AL Catapano","year":"2016","unstructured":"Catapano AL, Graham I, De Backer G, et al. 2016 ESC\/EAS guidelines for the management of dyslipidaemias. Eur Heart J. 2016;37(39):2999\u20133058.","journal-title":"Eur Heart J"},{"key":"1962_CR7","doi-asserted-by":"crossref","unstructured":"Ray KK, Molemans B, Schoonen WM, et al. EU-wide cross-sectional observational study of lipid-modifying therapy use in secondary and primary care: the DA VINCI study. Eur J Prevent Cardiol. 2021;28:1279\u201389.","DOI":"10.1093\/eurjpc\/zwaa047"},{"issue":"Suppl. 2","key":"1962_CR8","doi-asserted-by":"publisher","first-page":"ehaa946.3013","DOI":"10.1093\/ehjci\/ehaa946.3013","volume":"41","author":"KK Ray","year":"2020","unstructured":"Ray KK, Bruckert E, Van Hout B, Feudjo Tepie M, Bridges I, Sibartie M. Does evolocumab use in Europe match 2019 ESC\/EAS lipid guidelines? Results from the HEYMANS study. In: ESC Congress 2020. Virtual, 2020. Eur Heart J. 2020;41(Suppl. 2):ehaa946.3013. https:\/\/doi.org\/10.1093\/ehjci\/ehaa946.3013.","journal-title":"Eur Heart J."},{"issue":"11","key":"1962_CR9","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.006537","volume":"6","author":"B Gencer","year":"2017","unstructured":"Gencer B, Koskinas KC, Raber L, et al. Eligibility for PCSK9 inhibitors according to American College of Cardiology (ACC) and European Society of Cardiology\/European Atherosclerosis Society (ESC\/EAS) guidelines after acute coronary syndromes. J Am Heart Assoc. 2017;6(11): e006537.","journal-title":"J Am Heart Assoc"},{"key":"1962_CR10","doi-asserted-by":"crossref","unstructured":"Koskinas KC, Gencer B, Nanchen D, et al. Eligibility for PCSK9 inhibitors based on the 2019 ESC\/EAS and 2018 ACC\/AHA guidelines. Eur J Prev Cardiol. 2021;28:59-65.","DOI":"10.1177\/2047487320940102"},{"key":"1962_CR11","doi-asserted-by":"crossref","first-page":"w20244","DOI":"10.4414\/smw.2020.20244","volume":"150","author":"Y Rachamin","year":"2020","unstructured":"Rachamin Y, Meier R, Rosemann T, Langenegger S, Markun S. Statin treatment and LDL target value achievement in Swiss general practice\u2014a retrospective observational study. Swiss Med Wkly. 2020;150:w20244.","journal-title":"Swiss Med Wkly"},{"issue":"1","key":"1962_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, et al. 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111\u201388.","journal-title":"Eur Heart J"},{"issue":"09\u201310","key":"1962_CR13","first-page":"140","volume":"20","author":"WF Riesen","year":"2020","unstructured":"Riesen WF, Kaiser W, Gallino A, von Eckardstein A, Theus G-R, Beer JH. Neue ESC\/EAS-Dyslipid\u00e4mie-guidelines. Eine kommentierte \u00dcbersicht der AGLA. Swiss Med Forum. 2020;20(09\u201310):140\u20138.","journal-title":"Swiss Med Forum"},{"issue":"32","key":"1962_CR14","first-page":"2473","volume":"38","author":"A Vonbank","year":"2017","unstructured":"Vonbank A, Agewall S, Kjeldsen KP, et al. Comprehensive efforts to increase adherence to statin therapy. Eur Heart J. 2017;38(32):2473\u20139.","journal-title":"Eur Heart J"},{"key":"1962_CR15","unstructured":"Swiss Federal Office of Public Health. Specialties list. https:\/\/www.bag.admin.ch\/dam\/bag\/en\/dokumente\/kuv-leistungen\/arzneimittel\/Spezialit%C3%A4tenliste\/spezialitaetenliste-als-pdf-stand-vom-01-02-2020.pdf.download.pdf\/Spezialit%C3%A4tenliste%20als%20PDF%20Stand%20vom%2001.02.2020.pdf. Accessed Nov 13, 2020."},{"issue":"16","key":"1962_CR16","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1056\/NEJMoa1500858","volume":"372","author":"MS Sabatine","year":"2015","unstructured":"Sabatine MS, Giugliano RP, Wiviott SD, et al. Open-label study of long-term evaluation against LDLCI. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. N Engl J Med. 2015;372(16):1500\u20139.","journal-title":"N Engl J Med"},{"issue":"17","key":"1962_CR17","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1016\/j.jacc.2019.08.1024","volume":"74","author":"MJ Koren","year":"2019","unstructured":"Koren MJ, Sabatine MS, Giugliano RP, et al. Long-term efficacy and safety of evolocumab in patients with hypercholesterolemia. J Am Coll Cardiol. 2019;74(17):2132\u201346.","journal-title":"J Am Coll Cardiol"},{"issue":"47","key":"1962_CR18","first-page":"975","volume":"18","author":"A von Eckardstein","year":"2018","unstructured":"von Eckardstein A, Riesen WF, Carballo D, et al. Empfehlungen zur Pr\u00e4vention der Atherosklerose 2018: update der AGLA. Swiss Med Forum. 2018;18(47):975\u201380.","journal-title":"Swiss Med Forum"},{"key":"1962_CR19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijcard.2019.12.011","volume":"303","author":"B Gencer","year":"2020","unstructured":"Gencer B, Carballo D, Nanchen D, et al. Intensified lipid lowering using ezetimibe after publication of the IMPROVE-IT trial: a contemporary analysis from the SPUM-ACS cohort. Int J Cardiol. 2020;303:8\u201313.","journal-title":"Int J Cardiol"},{"issue":"1","key":"1962_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1161\/CIRCRESAHA.118.314191","volume":"124","author":"TM Kaufman","year":"2019","unstructured":"Kaufman TM, Warden BA, Minnier J, et al. Application of PCSK9 inhibitors in practice. Circ Res. 2019;124(1):32\u20137.","journal-title":"Circ Res"},{"issue":"5","key":"1962_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/1755-5922.12439","volume":"36","author":"B Zafrir","year":"2018","unstructured":"Zafrir B, Jubran A. Lipid-lowering therapy with PCSK9-inhibitors in the real-world setting: two-year experience of a regional lipid clinic. Cardiovasc Ther. 2018;36(5): e12439.","journal-title":"Cardiovasc Ther"},{"issue":"1","key":"1962_CR22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.5603\/CJ.a2017.0137","volume":"25","author":"M Saborowski","year":"2018","unstructured":"Saborowski M, D\u00f6lle M, Manns MP, Leitolf H, Zender S. Lipid-lowering therapy with PCSK9-inhibitors in the management of cardiovascular high-risk patients: effectiveness, therapy adherence and safety in a real world cohort. Cardiol J. 2018;25(1):32\u201341.","journal-title":"Cardiol J"},{"key":"1962_CR23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.atherosclerosis.2017.11.027","volume":"270","author":"RM Stoekenbroek","year":"2018","unstructured":"Stoekenbroek RM, Hartgers ML, Rutte R, de Wijer DD, Stroes ESG, Hovingh GK. PCSK9 inhibitors in clinical practice: delivering on the promise? Atherosclerosis. 2018;270:205\u201310.","journal-title":"Atherosclerosis"},{"issue":"12","key":"1962_CR24","first-page":"1270","volume":"23","author":"J Menzin","year":"2017","unstructured":"Menzin J, Aggarwal J, Boatman B, et al. Ezetimibe use and LDL-C goal achievement: a retrospective database analysis of patients with clinical atherosclerotic cardiovascular disease or probable heterozygous familial hypercholesterolemia. J Manag Care Spec Pharm. 2017;23(12):1270\u20136.","journal-title":"J Manag Care Spec Pharm"},{"key":"1962_CR25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.atherosclerosis.2019.03.014","volume":"285","author":"G De Backer","year":"2019","unstructured":"De Backer G, Jankowski P, Kotseva K, et al. Management of dyslipidaemia in patients with coronary heart disease: results from the ESC-EORP EUROASPIRE V survey in 27 countries. Atherosclerosis. 2019;285:135\u201346.","journal-title":"Atherosclerosis"},{"issue":"1","key":"1962_CR26","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.clinthera.2018.11.012","volume":"41","author":"CA Huber","year":"2019","unstructured":"Huber CA, Meyer MR, Steffel J, Blozik E, Reich O, Rosemann T. Post-myocardial infarction (MI) care: medication adherence for secondary prevention after MI in a large real-world population. Clin Ther. 2019;41(1):107\u201317.","journal-title":"Clin Ther"},{"key":"1962_CR27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.atherosclerosis.2020.09.023","volume":"314","author":"JK Stock","year":"2020","unstructured":"Stock JK. DA VINCI study: change in approach to cholesterol management will be needed to reduce the implementation gap between guidelines and clinical practice in Europe. Atherosclerosis. 2020;314:74\u20136.","journal-title":"Atherosclerosis"},{"issue":"5","key":"1962_CR28","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1001\/jamacardio.2019.0777","volume":"4","author":"SM Grundy","year":"2019","unstructured":"Grundy SM, Stone NJ. 2018 American Heart Association\/American College of Cardiology multisociety guideline on the management of blood cholesterol: primary prevention. JAMA Cardiol. 2019;4(5):488\u20139.","journal-title":"JAMA Cardiol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01962-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-021-01962-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01962-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,15]],"date-time":"2023-01-15T20:01:13Z","timestamp":1673812873000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-021-01962-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,18]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["1962"],"URL":"https:\/\/doi.org\/10.1007\/s12325-021-01962-w","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,18]]},"assertion":[{"value":"9 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}